A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer

FASEB Journal

Volumn 27, Issue 4, 2013, Pages 1404-1412

  Guan, Xiaoxiang ^a,b   Liu, Zhensheng ^b   Liu, Hongliang ^b   Yu, Hongping ^b   Wang, Li E ^b   Sturgis, Erich M ^b   Li, Guojun ^b   Wei, Qingyi ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Genetic susceptibility; Microrna; Polymorphism

Indexed keywords

CASPASE 3; CASPASE 4; CASPASE 6; CYTOSINE; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 885 5P; THYMINE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAZARD RATIO; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE BINDING SITE; PERIPHERAL BLOOD MONONUCLEAR CELL; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK; SECOND CANCER; STATISTICAL SIGNIFICANCE;

AGED; BINDING SITES; CARCINOMA, SQUAMOUS CELL; CASPASE 3; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

CITRUS MAXIMA;

EID: 84875700533     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-223420     Document Type: Article

References (46)

1. Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108.
2. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin. 61, 69-90.
3. Sturgis, E. M., and Miller, R. H. (1995) Second primary malignancies in the head and neck cancer patient. Ann. Otol. Rhinol. Laryngol. 104, 946-954.
4. Day, G. L., Blot, W. J., Shore, R. E., McLaughlin, J. K., Austin, D. F., Greenberg, R. S., Liff, J. M., Preston-Martin, S., Sarkar, S., Schoenberg, J. B., and Fraumenu, J. F. (1994) Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J. Natl. Cancer Inst. 86, 131-137.
5. Do, K. A., Johnson, M. M., Lee, J. J., Wu, X. F., Dong, Q., Hong, W. K., Khuri, F. R., and Spitz, M. R. (2004) Longitudinal study of smoking patterns in relation to the development of smokingrelated secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer 101, 2837-2842.
6. Ng, A. K., and Travis, L. B. (2008) Second primary cancers: an overview. Hematol Oncol Clin North Am 22, 271-289, vii.
7. Gilbert, E. S., Stovall, M., Gospodarowicz, M., Van Leeuwen, F. E., Andersson, M., Glimelius, B., Joensuu, T., Lynch, C. F., Curtis, R. E., Holowaty, E., Storm, H., Pukkala, E., van't Veer, M. B., Fraumeni, J. F., Boice , J. D., Jr., Clarke, E. A., and Travis, L. B. (2003) Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat. Res. 159, 161-173.
8. Danial, N. N., and Korsmeyer, S. J. (2004) Cell death: critical control points. Cell 116, 205-219.
9. Danial, N. N. (2007) BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin. Cancer Res. 13, 7254-7263.
10. Degterev, A., Boyce, M., and Yuan, J. (2003) A decade of caspases. Oncogene 22, 8543-8567.
11. Fesik, S. W. (2005) Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 5, 876-885.
12. Zeiss, C. J. (2003) The apoptosis-necrosis continuum: insights from genetically altered mice. Vet. Pathol. 40, 481-495.
13. Andersen, M. H., Becker, J. C., and Straten, P. (2005) Regulators of apoptosis: suitable targets for immune therapy of cancer. Nat. Rev. Drug. Discov. 4, 399-409.
14. Hengartner, M. O. (2000) The biochemistry of apoptosis. Nature 407, 770-776.
15. Soung, Y. H., Lee, J. W., Kim, S. Y., Park, W. S., Nam, S. W., Lee, J. Y., Yoo, N. J., and Lee, S. H. (2004) Somatic mutations of CASP3 gene in human cancers. Hum. Genet. 115, 112-115.
16. Kurokawa, H., Nishio, K., Fukumoto, H., Tomonari, A., Suzuki, T., and Saijo, N. (1999) Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol. Rep. 6, 33-37.
17. Fujikawa, K., Shiraki, K., Sugimoto, K., Ito, T., Yamanaka, T., Takase, K., and Nakano, T. (2000) Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma. Anticancer Res. 20, 1927-1932.
18. Kania, J., Konturek, S. J., Marlicz, K., Hahn, E. G., and Konturek, P. C. (2003) Expression of survivin and caspase-3 in gastric cancer. Dig. Dis. Sci. 48, 266-271.
19. Tormanen-Napankangas, U., Soini, Y., Kahlos, K., Kinnula, V., and Paakko, P. (2001) Expression of caspases-3, -6 and -8 and their relation to apoptosis in non-small cell lung carcinoma. Int. J. Cancer 93, 192-198.
20. Lee, J. W., Soung, Y. H., Kim, S. Y., Park, W. S., Nam, S. W., Lee, J. Y., Yoo, N. J., and Lee, S. H. (2006) Somatic mutation of pro-apoptosis caspase-6 gene is rare in breast and lung carcinomas. Pathology 38, 358-359.
21. Chen, K., Zhao, H., Hu, Z., Wang, L. E., Zhang, W., Sturgis, E. M., and Wei, Q. (2008) CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck. Clin. Cancer Res. 14, 6343-6349.
22. Li, C., Lu, J., Liu, Z., Wang, L. E., Zhao, H., El-Naggar, A. K., Sturgis, E. M., and Wei, Q. (2010) The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck. Cancer Prev. Res. (Phila.) 3, 246-253.
23. Lee, W. K., Kim, J. S., Kang, H. G., Cha, S. I., Kim, D. S., Hyun, D. S., Kam, S., Kim, C. H., Jung, T. H., and Park, J. Y. (2009) Polymorphisms in the Caspase7 gene and the risk of lung cancer. Lung Cancer 65, 19-24.
24. Xu, H. L., Xu, W. H., Cai, Q., Feng, M., Long, J., Zheng, W., Xiang, Y. B., and Shu, X. O. (2009) Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population. Cancer Epidemiol. Biomarkers Prev. 18, 2114-2122.
25. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
26. Carleton, M., Cleary, M. A., and Linsley, P. S. (2007) MicroRNAs and cell cycle regulation. Cell Cycle 6, 2127-2132.
27. Cho, W. C. (2010) MicroRNAs in cancer-from research to therapy. Biochim. Biophys. Acta 1805, 209-217.
28. Cho, W. C. (2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol. 42, 1273-1281.
29. Wong, T. S., Liu, X. B., Wong, B. Y., Ng, R. W., Yuen, A. P., and Wei, W. I. (2008) Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin. Cancer Res. 14, 2588-2592.
30. Ryan, B. M., Robles, A. I., and Harris, C. C. (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer 10, 389-402.
31. Chang, S. S., Jiang, W. W., Smith, I., Poeta, L. M., Begum, S., Glazer, C., Shan, S., Westra, W., Sidransky, D., and Califano, J. A. (2008) MicroRNA alterations in head and neck squamous cell carcinoma. Int. J. Cancer 123, 2791-2797.
32. Wald, A. I., Hoskins, E. E., Wells, S. I., Ferris, R. L., and Khan, S. A. (2011) Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 33, 504-512.
33. Zafereo, M. E., Sturgis, E. M., Liu, Z., Wang, L. E., Wei, Q., and Li, G. (2009) Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis 30, 997-1002.
34. Hu, Z., Chen, J., Tian, T., Zhou, X., Gu, H., Xu, L., Zeng, Y., Miao, R., Jin, G., Ma, H., Chen, Y., and Shen, H. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest. 118, 2600-2608.
35. Hu, Z., Liang, J., Wang, Z., Tian, T., Zhou, X., Chen, J., Miao, R., Wang, Y., Wang, X., and Shen, H. (2009) Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum. Mutat. 30, 79-84.
36. Sano, D., Xie, T. X., Ow, T. J., Zhao, M., Pickering, C. R., Zhou, G., Sandulache, V. C., Wheeler, D. A., Gibbs, R. A., Caulin, C., and Myers, J. N. (2011) Disruptive TP53 Mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clin. Cancer Res. 17, 6658-6670.
37. Han, Z., Wei, W., Dunaway, S., Darnowski, J. W., Calabresi, P., Sedivy, J., Hendrickson, E. A., Balan, K. V., Pantazis, P., and Wyche, J. H. (2002) Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J. Biol. Chem. 277, 17154-17160.
38. Song, F., Zheng, H., Liu, B., Wei, S., Dai, H., Zhang, L., Calin, G. A., Hao, X., Wei, Q., Zhang, W., and Chen, K. (2009) An miR-502-binding site single-nucleotide polymorphism in the 3=-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin. Cancer Res. 15, 6292-6300.
39. Liu, Z., Wei, S., Ma, H., Zhao, M., Myers, J. N., Weber, R. S., Sturgis, E. M., and Wei, Q. (2011) A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 32, 1668-1674.
40. Devarajan, E., Sahin, A. A., Chen, J. S., Krishnamurthy, R. R., Aggarwal, N., Brun, A. M., Sapino, A., Zhang, F., Sharma, D., Yang, X. H., Tora, A. D., and Mehta, K. (2002) Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 21, 8843-8851.
41. Isobe, N., Onodera, H., Mori, A., Shimada, Y., Yang, W., Yasuda, S., Fujimoto, A., Ooe, H., Arii, S., Kitaichi, M., and Imamura, M. (2004) Caspase-3 expression in human gastric carcinoma and its clinical significance. Oncology 66, 201-209.
42. Huang, Q., Li, F., Liu, X., Li, W., Shi, W., Liu, F. F., O'Sullivan, B., He, Z., Peng, Y., Tan, A. C., Zhou, L., Shen, J., Han, G., Wang, X. J., Thorburn, J., Thorburn, A., Jimeno, A., Raben, D., Bedford, J. S., and Li, C. Y. (2011) Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat. Med. 17, 860-866.
43. Lan, Q., Zheng, T., Chanock, S., Zhang, Y., Shen, M., Wang, S. S., Berndt, S. I., Zahm, S. H., Holford, T. R., Leaderer, B., Yeager, M., Welch, R., Hosgood, D., Boyle, P., and Rothman, N. (2007) Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis 28, 823-827.
44. Sun, T., Gao, Y., Tan, W., Ma, S., Shi, Y., Yao, J., Guo, Y., Yang, M., Zhang, X., Zhang, Q., Zeng, C., and Lin, D. (2007) A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat. Genet. 39, 605-613.
45. Park, J. Y., Park, J. M., Jang, J. S., Choi, J. E., Kim, K. M., Cha, S. I., Kim, C. H., Kang, Y. M., Lee, W. K., Kam, S., Park, R. W., Kim, I. S., Lee, J. T., and Jung, T. H. (2006) Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum. Mol. Genet. 15, 1963-1971.
46. Afanasyeva, E. A., Mestdagh, P., Kumps, C., Vandesompele, J., Ehemann, V., Theissen, J., Fischer, M., Zapatka, M., Brors, B., Savelyeva, L., Sagulenko, V., Speleman, F., Schwab, M., and Westermann, F. (2011) MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival. Cell Death Differ. 18, 974-984.